» Articles » PMID: 6967358

Components of Mycobacteria and Muramyl Dipeptide with Adjuvant Activity Induce Lymphocyte Activating Factor

Overview
Journal Cell Immunol
Publisher Elsevier
Date 1980 Mar 1
PMID 6967358
Citations 44
Authors
Affiliations
Soon will be listed here.
Citing Articles

Deletion of Card9 eliminates the detrimental facets of mycobacterial adjuvants.

Mitsuyama H, Iizasa E, Kukita A, Toda S, Yoshida H, Inoue H Heliyon. 2024; 10(19):e38139.

PMID: 39386804 PMC: 11462255. DOI: 10.1016/j.heliyon.2024.e38139.


Strategies for Using Muramyl Peptides - Modulators of Innate Immunity of Bacterial Origin - in Medicine.

Guryanova S, Khaitov R Front Immunol. 2021; 12:607178.

PMID: 33959120 PMC: 8093441. DOI: 10.3389/fimmu.2021.607178.


Muramyl dipeptide enhances lipopolysaccharide-induced osteoclast formation and bone resorption through increased RANKL expression in stromal cells.

Ishida M, Kitaura H, Kimura K, Sugisawa H, Aonuma T, Takada H J Immunol Res. 2015; 2015:132765.

PMID: 26000311 PMC: 4427123. DOI: 10.1155/2015/132765.


Vaxjo: a web-based vaccine adjuvant database and its application for analysis of vaccine adjuvants and their uses in vaccine development.

Sayers S, Ulysse G, Xiang Z, He Y J Biomed Biotechnol. 2012; 2012:831486.

PMID: 22505817 PMC: 3312338. DOI: 10.1155/2012/831486.


Adjuvants et stimulants de l'immunité: propriétés immunorégulatrices du muramyl-dipeptide, des corynébactéries anaérobies et du diéthyldithiocarbamate de sodium.

Archambault D, Morin G Can Vet J. 1988; 29(1):51-8.

PMID: 17422948 PMC: 1680745.